Chimeric Bait Receptors for Combatting Airborne Viral Infections Can Be Delivered Intranasally
Chimeric Bait Receptors for Combatting Airborne Viral Infections Can Be Delivered Intranasally
Hemogenyx Pharmaceuticals plc (LSE: HEMO) is pleased to announce that it has been informed by the U.S. Federal Food and Drug Administration (“FDA”) that it has lifted the clinical hold on the Investigational
HemoGenyx Pharmaceuticals (LON: HEMO) announced the approval of a crucial patent application by the United States Patent and Trademark Office, safeguarding its innovative CDX antibody technology.
Submission of Complete Response to Clinical Hold for HEMO-CAR-T IND
Chimeric Bait Receptor-programmed macrophages show promise for the treatment of Non-Hodgkin Lymphoma
Appointment of Administrators
Scotgold Resources Limited (“Scotgold”, the “Company” or the “Group”) Planned Appointment of Administrators
On 29 September, the Company announced that financing discussions were ongoing and that should sufficient financing not be secured it would need to appoint an Administrator.
On 11 September 2023, the Company announced an update on the Mining Plus review of the Cononish Mine plan for the next twelve months, encompassing a geological review of the
Hemogenyx Pharmaceuticals Announces Strategic Investment from Prevail Partners, LLC
Scotgold Resources Limited’s shares (AIM: SGZ) surged by 18% as it secured the much-needed financial support of US$500,000 and announced a cost-effective ore extraction method at its mine near Loch
Scotgold Resources Limited (AIM: SGZ), Scotland’s first commercial gold producer, announces an operational and corporate update f or its Cononish Gold and Silver Mine in Scotland (“Cononish”).